Mark W. Stahlhut

3.2k total citations
45 papers, 1.7k citations indexed

About

Mark W. Stahlhut is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Mark W. Stahlhut has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 21 papers in Molecular Biology and 18 papers in Virology. Recurrent topics in Mark W. Stahlhut's work include HIV/AIDS drug development and treatment (31 papers), HIV Research and Treatment (18 papers) and Hepatitis C virus research (17 papers). Mark W. Stahlhut is often cited by papers focused on HIV/AIDS drug development and treatment (31 papers), HIV Research and Treatment (18 papers) and Hepatitis C virus research (17 papers). Mark W. Stahlhut collaborates with scholars based in United States, Italy and Canada. Mark W. Stahlhut's co-authors include David B. Olsen, Hie‐Won Hann, Steven S. Carroll, H W Hann, Lawrence C. Kuo, B. S. Blumberg, Carrie A. Rutkowski, Malcolm MacCoss, Christine L. Hann and Joanne E. Tomassini and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Mark W. Stahlhut

45 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark W. Stahlhut United States 21 656 600 472 390 264 45 1.7k
André Kirn France 26 755 1.2× 523 0.9× 538 1.1× 611 1.6× 291 1.1× 57 2.0k
Marian Gorecki Israel 31 305 0.5× 971 1.6× 93 0.2× 302 0.8× 78 0.3× 63 2.2k
Hiroo Hoshino Japan 29 458 0.7× 746 1.2× 70 0.1× 335 0.9× 165 0.6× 99 2.3k
Hon C. Hui United States 20 572 0.9× 580 1.0× 54 0.1× 226 0.6× 367 1.4× 25 1.3k
J P Sommadossi United States 21 1.1k 1.7× 774 1.3× 285 0.6× 666 1.7× 326 1.2× 49 2.0k
Ted Fox United States 18 198 0.3× 1.3k 2.1× 449 1.0× 435 1.1× 122 0.5× 24 2.0k
Arnold Fridland United States 36 2.2k 3.4× 1.4k 2.3× 182 0.4× 938 2.4× 215 0.8× 77 3.6k
Mike Westby United Kingdom 22 1.5k 2.2× 824 1.4× 292 0.6× 552 1.4× 126 0.5× 46 3.0k
Warren N. Schmidt United States 30 232 0.4× 1.0k 1.7× 1.4k 3.0× 1.2k 3.0× 23 0.1× 104 3.0k
Michele Connelly United States 30 661 1.0× 1.6k 2.7× 55 0.1× 486 1.2× 452 1.7× 66 3.1k

Countries citing papers authored by Mark W. Stahlhut

Since Specialization
Citations

This map shows the geographic impact of Mark W. Stahlhut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Stahlhut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Stahlhut more than expected).

Fields of papers citing papers by Mark W. Stahlhut

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Stahlhut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Stahlhut. The network helps show where Mark W. Stahlhut may publish in the future.

Co-authorship network of co-authors of Mark W. Stahlhut

This figure shows the co-authorship network connecting the top 25 collaborators of Mark W. Stahlhut. A scholar is included among the top collaborators of Mark W. Stahlhut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark W. Stahlhut. Mark W. Stahlhut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carroll, Steve S., John A. McCauley, Paul J. Coleman, et al.. (2010). MK-5172, a Novel Macrocyclic Inhibitor of NS3/4a Protease Demonstrates Efficacy Against Viral Resistance in the Chimpanzee Model of Chronic Hepatitis C Virus Infection. Antiviral Research. 86(1). A21–A21. 1 indexed citations
2.
McCauley, John A., Michael T. Rudd, Kevin T. Nguyen, et al.. (2008). Bismacrocyclic Inhibitors of Hepatitis C NS3/4a Protease. Angewandte Chemie International Edition. 47(47). 9104–9107. 18 indexed citations
3.
Butora, Gabor, David B. Olsen, Steven S. Carroll, et al.. (2007). Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2′-C-methyladenosine. Bioorganic & Medicinal Chemistry. 15(15). 5219–5229. 24 indexed citations
4.
Raghavan, Subharekha, Zhijian Lu, Kevin T. Chapman, et al.. (2007). Synthesis of novel HIV protease inhibitors (PI) with activity against PI-resistant virus. Bioorganic & Medicinal Chemistry Letters. 17(19). 5432–5436. 8 indexed citations
5.
Smith, Amos B., Adam K. Charnley, Hironori Harada, et al.. (2005). Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2′ side chains. Bioorganic & Medicinal Chemistry Letters. 16(4). 859–863. 18 indexed citations
6.
Kim, Ronald M., Kevin T. Chapman, William A. Schleif, et al.. (2004). P1′ oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. Bioorganic & Medicinal Chemistry Letters. 14(18). 4651–4654. 21 indexed citations
7.
Lu, Zhijian, Subharekha Raghavan, Mark G. Charest, et al.. (2003). Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus. Bioorganic & Medicinal Chemistry Letters. 13(10). 1821–1824. 12 indexed citations
8.
Carroll, Steven S., Joanne E. Tomassini, Michele Bosserman, et al.. (2003). Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs. Journal of Biological Chemistry. 278(14). 11979–11984. 281 indexed citations
9.
Duffy, Joseph, Brian A. Kirk, Kevin T. Chapman, et al.. (2003). HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent. Bioorganic & Medicinal Chemistry Letters. 13(19). 3323–3326. 10 indexed citations
10.
Cheng, Yuan, Fengqi Zhang, Thomas A. Rano, et al.. (2002). Indinavir analogues with blocked metabolism sites as HIV protease inhibitors with improved pharmacological profiles and high potency against PI-Resistant viral strains. Bioorganic & Medicinal Chemistry Letters. 12(17). 2419–2422. 23 indexed citations
11.
Raghavan, Subharekha, Zheng Rong Yang, Ralph T. Mosley, et al.. (2002). Combinatorial library of indinavir analogues: replacement for the aminoindanol at P2′. Bioorganic & Medicinal Chemistry Letters. 12(20). 2855–2858. 6 indexed citations
12.
Olsen, David B., Fritz Benseler, James L. Cole, et al.. (1996). Elucidation of Basic Mechanistic and Kinetic Properties of Influenza Endonuclease Using Chemically Synthesized RNAs. Journal of Biological Chemistry. 271(13). 7435–7439. 20 indexed citations
13.
Stahlhut, Mark W. & David B. Olsen. (1996). [8] Expression and purification of retroviral HIV-1 reverse transcriptase. Methods in enzymology on CD-ROM/Methods in enzymology. 275. 122–133. 10 indexed citations
14.
Carroll, Steven S., James Geib, David B. Olsen, et al.. (1994). Sensitivity of HIV-1 Reverse Transcriptase and Its Mutants to Inhibition by Azidothymidine Triphosphate. Biochemistry. 33(8). 2113–2120. 51 indexed citations
15.
Stahlhut, Mark W., Jon H. Condra, Jing-Li Fu, et al.. (1994). Purification and Characterization of HIV-1 Reverse Transcriptase Having a 1:1 Ratio of p66 and p51 Subunits. Protein Expression and Purification. 5(6). 614–621. 9 indexed citations
16.
Stahlhut, Mark W., et al.. (1990). Effect of Iron and Desferoxamine on Cell Growth And In Vitro Ferritin Synthesis in Human Hepatoma Cell Lines. Hepatology. 11(4). 566–569. 89 indexed citations
17.
Hann, Hie‐Won, Beverly Lange, Mark W. Stahlhut, & Katherine A. McGlynn. (1990). Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease. Cancer. 66(2). 313–316. 33 indexed citations
18.
Hann, Hie‐Won, Mark W. Stahlhut, Stephen Lee, W. Thomas London, & Richard S. Hann. (1989). Effects of isoferritins on human granulocytes. Cancer. 63(12). 2492–2496. 24 indexed citations
19.
Hann, H W, Mark W. Stahlhut, & Andrea Evans. (1986). Source of Increased Ferritin in Neuroblastoma: Studies With Concanavalin A-Sepharose Binding<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 76(6). 1031–3. 19 indexed citations
20.
Hann, Hie‐Won, Mark W. Stahlhut, & Irving Millman. (1984). Human ferritins present in the sera of nude mice transplanted with human neuroblastoma or hepatocellular carcinoma.. PubMed. 44(9). 3898–901. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Kirn Breakdown of academic impact, for papers by Marian Gorecki Breakdown of academic impact, for papers by Hiroo Hoshino Breakdown of academic impact, for papers by Hon C. Hui Breakdown of academic impact, for papers by J P Sommadossi Breakdown of academic impact, for papers by Ted Fox Breakdown of academic impact, for papers by Arnold Fridland Breakdown of academic impact, for papers by Mike Westby Breakdown of academic impact, for papers by Warren N. Schmidt Breakdown of academic impact, for papers by Michele Connelly
Rankless by CCL
2026